Search research articles
Contact Us
Filters
Showing results (1-10 of 53) with videos related to
Page
of 6
Sort By:
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|
January 17, 2017
Staking a claim
Anthony Mills
Clinical Cornerstone
|
May 3, 2006
Improvement in sexual functioning and satisfaction in nonresponders to testosterone gel: clinical effectiveness in hypogonadal, HIV-positive males
Shannon Schrader, Anthony Mills, Mark Scheperle, et al.
Antiviral Therapy
|
May 22, 2023
The evolution of clinical study design in heavily treatment-experienced persons with HIV: A critical review
Judith A Aberg, Anthony Mills, Santiago Moreno, et al.
The Patient
|
June 6, 2015
Patient-Reported Symptoms Over 48 Weeks in a Randomized, Open-Label, Phase IIIb Non-Inferiority Trial of Adults with HIV Switching to Co-Formulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir DF versus Continuation of Non-Nucleoside Reverse Transcriptase Inhibitor with Emtricitabine and Tenofovir DF
Anthony Mills, Will Garner, Anton Pozniak, et al.
Current HIV Research
|
October 16, 2010
Etravirine in the treatment of HIV-1: a clinical overview for healthcare professionals
Patrick Yeni, Anthony Mills, Monika Peeters, et al.
Pest Management Science
|
May 31, 2020
Influence of flooding period and seed burial depth on Palmer amaranth (Amaranthus palmeri) seed germination
Lucas X Franca, Darrin M Dodds, Daniel B Reynolds, et al.
Clinical Drug Investigation
|
September 3, 2016
Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice
Philip Lackey, Anthony Mills, Felix Carpio, et al.
AIDS Research and Human Retroviruses
|
January 26, 2018
Superior Efficacy and Improved Renal and Bone Safety After Switching from a Tenofovir Disoproxil Fumarate- to a Tenofovir Alafenamide-Based Regimen Through 96 Weeks of Treatment
Edwin DeJesus, Bernard Haas, Sorana Segal-Maurer, et al.
European Journal of Haematology
|
September 16, 2021
A low-dose rituximab regimen for first-line treatment of acquired haemophilia A
Stewart Hunt, Jeremy Robertson, Jason Conn, et al.
AIDS (London, England)
|
May 26, 2018
Coformulated bictegravir, emtricitabine, tenofovir alafenamide after initial treatment with bictegravir or dolutegravir and emtricitabine/tenofovir alafenamide
Paul E Sax, Edwin DeJesus, Gordon Crofoot, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 53) with videos related to
Sort By:
Page
of 6
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|
January 17, 2017
Staking a claim
Anthony Mills
Clinical Cornerstone
|
May 3, 2006
Improvement in sexual functioning and satisfaction in nonresponders to testosterone gel: clinical effectiveness in hypogonadal, HIV-positive males
Shannon Schrader, Anthony Mills, Mark Scheperle, et al.
Antiviral Therapy
|
May 22, 2023
The evolution of clinical study design in heavily treatment-experienced persons with HIV: A critical review
Judith A Aberg, Anthony Mills, Santiago Moreno, et al.
The Patient
|
June 6, 2015
Patient-Reported Symptoms Over 48 Weeks in a Randomized, Open-Label, Phase IIIb Non-Inferiority Trial of Adults with HIV Switching to Co-Formulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir DF versus Continuation of Non-Nucleoside Reverse Transcriptase Inhibitor with Emtricitabine and Tenofovir DF
Anthony Mills, Will Garner, Anton Pozniak, et al.
Current HIV Research
|
October 16, 2010
Etravirine in the treatment of HIV-1: a clinical overview for healthcare professionals
Patrick Yeni, Anthony Mills, Monika Peeters, et al.
Pest Management Science
|
May 31, 2020
Influence of flooding period and seed burial depth on Palmer amaranth (Amaranthus palmeri) seed germination
Lucas X Franca, Darrin M Dodds, Daniel B Reynolds, et al.
Clinical Drug Investigation
|
September 3, 2016
Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice
Philip Lackey, Anthony Mills, Felix Carpio, et al.
AIDS Research and Human Retroviruses
|
January 26, 2018
Superior Efficacy and Improved Renal and Bone Safety After Switching from a Tenofovir Disoproxil Fumarate- to a Tenofovir Alafenamide-Based Regimen Through 96 Weeks of Treatment
Edwin DeJesus, Bernard Haas, Sorana Segal-Maurer, et al.
European Journal of Haematology
|
September 16, 2021
A low-dose rituximab regimen for first-line treatment of acquired haemophilia A
Stewart Hunt, Jeremy Robertson, Jason Conn, et al.
AIDS (London, England)
|
May 26, 2018
Coformulated bictegravir, emtricitabine, tenofovir alafenamide after initial treatment with bictegravir or dolutegravir and emtricitabine/tenofovir alafenamide
Paul E Sax, Edwin DeJesus, Gordon Crofoot, et al.
Page
of 6